COVID-19 and New Myocardial Infarction Risk
Author Information
Author(s): Ayman El-Menyar, Ramzee Ahmed Faidh, Asim Mohammad, Shahid Fakhar, Ata Yaser M, El Baba Hamzah, Fino Areen, Nair Arun P, Peralta Ruben, Almaslamani Muna A, Al Suwaidi Jassim, Al-Thani Hassan, Rizoli Sandro
Primary Institution: Hamad Medical Corporation, Doha, Qatar
Hypothesis
COVID-19 increases the rate of repeated AMI in patients with old MI regardless of age and gender.
Conclusion
Patients with old MI could develop a new AMI in 80% of COVID-19 cases, with higher mortality in those without a history of MI due to COVID-19 severity.
Supporting Evidence
- Among 16,903 patients with COVID-19, 210 developed thromboembolic events.
- 92.5% of patients with prior MI developed another AMI.
- COVID-19 severity was an independent predictor of mortality.
Takeaway
If someone had a heart problem before getting COVID-19, they are very likely to have another heart problem while sick with COVID-19.
Methodology
A retrospective analysis of adult patients with COVID-19 who developed thromboembolic events.
Potential Biases
Potential for unmeasured confounding factors and missed diagnoses of clinically insignificant TEE.
Limitations
The study is retrospective, which may include missing information and lacks a control group without prior MI.
Participant Demographics
89% male, 55% under 55 years old, 80.5% had prior MI.
Statistical Information
P-Value
0.014
Confidence Interval
1.617-67.194
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website